Beijing Wandong Medical Technology Co.,Ltd. (SHA:600055)
China · Delayed Price · Currency is CNY 10.75
+0.28 (2.67%)
Oct 23, 2026, 3:00 PM CST
SHA:600055 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,579 | 3,268 | 3,586 | 3,437 | 3,241 | 885.88 |
Trading Asset Securities | 345.49 | - | - | 3.59 | 100.37 | 246.49 |
Cash & Short-Term Investments | 2,925 | 3,268 | 3,586 | 3,441 | 3,342 | 1,132 |
Cash Growth | -6.15% | -8.87% | 4.23% | 2.96% | 195.11% | -2.89% |
Accounts Receivable | 571.99 | 439.36 | 385.17 | 269.85 | 312.83 | 201.95 |
Other Receivables | 27.38 | 226.09 | 238.01 | 276.95 | 270.14 | 286.68 |
Receivables | 599.37 | 665.45 | 623.18 | 546.79 | 582.97 | 488.62 |
Inventory | 274.58 | 637.47 | 214.94 | 377.8 | 266.62 | 192.29 |
Other Current Assets | 253.04 | 34.64 | 26.87 | 38.44 | 74.96 | 47.66 |
Total Current Assets | 4,052 | 4,606 | 4,451 | 4,404 | 4,266 | 1,861 |
Property, Plant & Equipment | 305.1 | 314.72 | 255.83 | 193.43 | 191.16 | 190.45 |
Long-Term Investments | 357.06 | 354.98 | 356.62 | 361.18 | 327.87 | 325.8 |
Other Intangible Assets | 16.64 | 20.48 | 26.77 | 12.43 | 20.05 | 26.02 |
Long-Term Accounts Receivable | - | 32.75 | 43.6 | 85.03 | 115.18 | 135.73 |
Long-Term Deferred Tax Assets | 137.34 | 149.25 | 74.32 | 71.63 | 77.58 | 62.34 |
Long-Term Deferred Charges | 84.78 | 75.07 | 51.12 | 32.21 | 21.47 | 26.24 |
Other Long-Term Assets | 239.97 | 206 | 210.86 | 236.53 | 242.95 | 248.46 |
Total Assets | 5,193 | 5,759 | 5,470 | 5,396 | 5,263 | 2,876 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 424.48 | 791.08 | 325.29 | 274.01 | 288.85 | 166.29 |
Accrued Expenses | 75.59 | 118.25 | 81.94 | 77.46 | 84.59 | 68.94 |
Current Portion of Long-Term Debt | - | 5.79 | 5.4 | 0.76 | 0.65 | 0.75 |
Current Portion of Leases | - | 8.02 | 6.42 | 5.33 | 6.26 | 4.14 |
Current Income Taxes Payable | - | 1.22 | 1.28 | 1.36 | 8.64 | 2.7 |
Current Unearned Revenue | 108.54 | 174.68 | 76.8 | 129.52 | 66.74 | 49.75 |
Other Current Liabilities | 74.68 | 48.82 | 37.62 | 37.1 | 36.34 | 35.78 |
Total Current Liabilities | 683.28 | 1,148 | 534.75 | 525.54 | 492.08 | 328.35 |
Long-Term Leases | 8.54 | 15.85 | 14.55 | 11.49 | 15.66 | 14.07 |
Long-Term Unearned Revenue | 84.9 | 11.74 | 19.59 | 20.55 | 26.64 | 12.28 |
Pension & Post-Retirement Benefits | 15.41 | 15.41 | 19.26 | 17.93 | 17.02 | 16.74 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.17 | 0.4 | 0.92 |
Other Long-Term Liabilities | - | - | 4.35 | 0.01 | 0.19 | 0.57 |
Total Liabilities | 792.13 | 1,191 | 592.5 | 575.7 | 551.98 | 372.92 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 703.06 | 703.06 | 703.06 | 703.06 | 703.06 | 540.82 |
Additional Paid-In Capital | - | 2,807 | 2,770 | 2,778 | 2,775 | 883.32 |
Retained Earnings | 835.77 | 979.78 | 1,299 | 1,233 | 1,129 | 1,024 |
Treasury Stock | -60 | -30 | - | - | - | -50.94 |
Comprehensive Income & Other | 2,810 | -2.18 | -5.01 | -3.06 | -1.71 | -1.04 |
Total Common Equity | 4,289 | 4,458 | 4,768 | 4,711 | 4,605 | 2,396 |
Minority Interest | 112.17 | 110.51 | 110.44 | 109.15 | 105.21 | 107.04 |
Shareholders' Equity | 4,401 | 4,568 | 4,878 | 4,821 | 4,711 | 2,503 |
Total Liabilities & Equity | 5,193 | 5,759 | 5,470 | 5,396 | 5,263 | 2,876 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.54 | 29.65 | 26.37 | 17.58 | 22.58 | 18.95 |
Net Cash (Debt) | 2,916 | 3,239 | 3,560 | 3,423 | 3,319 | 1,113 |
Net Cash Growth | -5.87% | -9.03% | 4.00% | 3.14% | 198.11% | -3.70% |
Net Cash Per Share | 4.14 | 4.61 | 5.07 | 4.88 | 5.03 | 2.08 |
Filing Date Shares Outstanding | 697.79 | 703.06 | 703.06 | 703.06 | 703.06 | 698.12 |
Total Common Shares Outstanding | 697.79 | 703.06 | 703.06 | 703.06 | 703.06 | 535.88 |
Working Capital | 3,369 | 3,458 | 3,917 | 3,878 | 3,774 | 1,533 |
Book Value Per Share | 6.15 | 6.34 | 6.78 | 6.70 | 6.55 | 4.47 |
Tangible Book Value | 4,272 | 4,437 | 4,741 | 4,699 | 4,585 | 2,370 |
Tangible Book Value Per Share | 6.12 | 6.31 | 6.74 | 6.68 | 6.52 | 4.42 |
Buildings | - | 224.84 | 209.86 | 161.22 | 157.75 | 156.25 |
Machinery | - | 282.16 | 221.7 | 189.75 | 173.69 | 165.85 |
Construction In Progress | - | 15.79 | 11.8 | 2.82 | 1.32 | - |